BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, October 18, 2024
See today's BioWorld Asia
Home
» US FDA makes history with 30 drugs approved in March
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Biopharma regulatory actions and approvals March 2024
US FDA makes history with 30 drugs approved in March
April 23, 2024
By
Amanda Lanier
No Comments
In March, the U.S. FDA approved 30 new drugs, marking the highest monthly count in
BioWorld’s
records. The previous highest month of June 2020, with 29 FDA approvals, is followed by November 2017’s 27 approvals.
BioWorld Asia
Analysis and data insight
Regulatory
U.S.
FDA